Glucagon‐like peptide‐1 analogues and thyroid cancer: An analysis of cases reported in the European pharmacovigilance database

202039 citationsJournal Article

Authors

Abstract

Our findings showed disproportionality for thyroid cancer, medullary thyroid cancer and thyroid neoplasm in patients treated with GLP-1 analogues. We have found evidence from spontaneous reports that GLP-1 analogues are associated with thyroid cancer in patients with diabetes.

Topics & Keywords

Diabetes Treatment and Management Neuroendocrine Tumor Research Advances Pharmacovigilance and Adverse Drug Reactions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Pharmacy and Therapeutics

Volume 46, Issue 1, pp. 99-105

DOI: 10.1111/jcpt.13259

Field-Weighted Citation Impact: 2.13